Biomedical Engineering Reference
In-Depth Information
46. Speckmann EJ, Hescheler J, Köhling R (2008) Physiologie, 5th edn. Urban & Fischer,
Munich
47. Schmidt RF, Lang F (2007) Physiologie des Menschen, 30th edn. Springer, Berlin
48. Dohmen PM, Hauptmann S, Terytze A, Konertz WF (2007) In vivo repopularization of a
tissue-engineered heart valve in a human subject. J Heart Valve Dis 16(4):447-449
49. Rajani B, Mee RB, Ratliff NB (1998) Evidence for rejection of homograft cardiac valves in
infants. J Thorac Cardiovasc Surg 115(1):111-117
50. Breinholt JP 3rd, Hawkins JA, Lambert LM et al (2000) A prospective analysis of the
immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery.
Circulation 102:179-182
51. Bechtel JF, Bartels C, Schmidtke C et al (2001) Does histocompatibility affect homograft
valve function after the Ross procedure? Circulation 104:I25-I28
52. Shaddy RE, Thompson DD, Osborne KA et al (1997) Persistence of human leukocyte antigen
(HLA) antibodies after one year in children receiving cryopreserved valved allografts. Am J
Cardiol 80(3):358-359
53. Shaddy RE, Hawkins JA (2002) Immunology and failure of valved allografts in children. Ann
Thorac Surg 74(4):1271-1275
54. Vogt PR, Stallmach T, Niederhäuser U et al (1999) Explanted cryopreserved allografts: a
morphological and immunohistochemical comparison between arterial allografts and
allograft heart valves from infants and adults. Eur J Cardiothorac Surg 15(5):639-644;
discussion 644-645
55. da Costa FD, Dohmen PM, Duarte D et al (2005) Immunological and echocardiographic
evaluation of decellularized versus cryopreserved allografts during the Ross operation. Eur J
Cardiothorac Surg 27(4):572-578
56. Zehr KJ, Yagubyan M, Connolly HM et al (2005) Aortic root replacement with a novel
decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early
results. J Thorac Cardiovasc Surg 130(4):1010-1015
57. Elkins RC, Lane MM, Capps SB et al (2001) Humoral immune response to allograft valve
tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg 13(4
Suppl 1):82-86
58. Bechtel JF, Müller-Steinhardt M, Schmidtke C et al (2003) Evaluation of the decellularized
pulmonary valve homograft (Synergraft). J Heart Valve Dis 734-739; discussion 739-740
59. Hawkins JA, Hillman ND, Lambert LM et al (2003) Immunogenicity of decellularized
cryopreserved allografts in pediatric cardiac surgery: comparison with standard
cryopreserved allografts. J Thorac Cardiovasc Surg 126(1):247-252; discussion 252-253
60. Kasimir MT, Rieder E, Seebacher G et al (2006) Decellularization does not eliminate
thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves.
J Heart Valve Dis 15(2):278-86; discussion 286
61. Rüffer A, Purbojo A, Cicha I et al (2010) Early failure of xenogenous de-cellularised
pulmonary valve conduits-a word of caution, Eur J Cardiothorac Surg 38(1):78-85
62. Elkins RC, Dawson PE, Goldstein S et al (2001) Decellularized human valve allografts. Ann
Thorac Surg 71:S428-S432
63. Hawkins JA, Breinholt JP, Lambert LM et al (2000) Class I and class II anti-HLA antibodies
after implantation of cryopreserved allograft. J Thorac Cardiovasc Surg 119(2):324-330
64. Akhyari P, Kamiya H, Gwanmesia P, Aubin H, Tschierschke R, Hoffmann S, Karck M,
Lichtenberg A (2010) In vivo functional performance and structural maturation of
decellularized allogenic aortic valves in the subcoronary position. Eur J Cardiothorac Surg
38(5):539-546
65. Affonso da Costa FD, Dohmen PM, Lopes SV, Lacerda G, Pohl F, Vilani R, Affonso da Costa
MB, Vieira ED, Yoschi S, Konertz W, Affonso da Costa I (2004) Comparison of
cryopreserved homografts and decellularized porcine heterografts implanted in sheep. Artif
Organs 28(4):366-370
Search WWH ::
Custom Search